Conference item
Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 406.0KB, Terms of use)
-
- Publisher copy:
- 10.1089/hum.2018.29077.abstracts
Authors
- Publisher:
- Mary Ann Liebert
- Host title:
- Human Gene Therapy
- Journal:
- Human Gene Therapy More from this journal
- Volume:
- 29
- Issue:
- 12
- Pages:
- A118
- Publication date:
- 2018-10-15
- Acceptance date:
- 2018-07-16
- DOI:
- EISSN:
-
1557-7422
- ISSN:
-
1043-0342
- Keywords:
- Pubs id:
-
pubs:962976
- UUID:
-
uuid:704eab53-7007-43fc-9d65-5cf129254555
- Local pid:
-
pubs:962976
- Source identifiers:
-
962976
- Deposit date:
-
2019-06-18
- ARK identifier:
Terms of use
- Copyright holder:
- Mary Ann Liebert, Inc
- Copyright date:
- 2018
- Notes:
- © 2018 Mary Ann Liebert, Inc. Conference abstract from 'Changing the Face of Modern Medicine: Stem Cell and Gene Therapy', organized jointly by the European Society of Gene and Cell Therapy (ESGCT), the International Society for Stem Cell Research (ISSCR) and the French Society of Gene and Cell Therapy (SFTCG) Lausanne, Switzerland October 16–19, 2018. This is the accepted manuscript version of the article. The final version is available online from Mary Ann Liebert at: https://doi.org/10.1089/hum.2018.29077.abstracts
If you are the owner of this record, you can report an update to it here: Report update to this record